Molecular Medicine sits at the forefront of its field, rapidly disseminating discovery in the genetic, molecular, and cellular basis of physiology and disease across a broad range of specialties. With over two decades of experience publishing to a multidisciplinary audience, and continually celebrating innovation through the ‘Ross Prize in Molecular Medicine’ and ‘Anthony Cerami Award in Translational Medicine’, the journal strives towards the design of better molecular tools for disease diagnosis, treatment and prevention.
Update
We welcome pre-submission inquiries to help you determine if your manuscript is a good fit for the journal. Please email your pre-submission inquiry, including a brief summary of your manuscript and its significance to the field, to cam…
We are recruiting Associate Editors to join the Molecular Medicine Editorial Board. Learn more about the role and how to apply here!
Molecular Medicine would like to recognize the efforts of its exceptional peer reviewers, for their excellent service. The following individuals have exceeded expectations as far as acceptance rate, the number of completed reviews, and timeliness, for each of the listed three-month periods. The journal cannot succeed without its peer reviewers, and we thank the hard-working members of our network.
First Quarter of 2025: Vivek Verma, PhD, University of Minnesota, USA
Second Quarter of 2025: Barbara Vona, PhD, University Medical Center Göttingen, Germany
Congratulations to Drs. Michel Sadelain and Carl H. June, winners of the 2026 Ross Prize in Molecular Medicine!
